This study aimed to compare the characteristics of patients with hematologic malignancies and solid cancers who received palliative care. A total of 124 patients with hematologic malignancy and 3032 patients with solid cancer, who received palliative care consultation services between 2006 and 2010 in a medical center in Taiwan, were retrospectively analyzed. Higher prevalence of oral stomatitis, diarrhea, and hematologic symptoms including infection, fever, severe anemia, and bleeding, and lower prevalence of constipation, abdominal distension, and pain were observed in patients with hematologic malignancies compared to that in patients with solid cancer. The interval from hospital admission to palliative care referral was longer for patie...
Objective: Close collaboration between the cancer care team service and the psychiatric consultation...
Background: It is important to know and decide when to end regimen for the quality of life of the pa...
Background: People with hematological malignancies can deteriorate rapidly to a terminal event and h...
This study aimed to compare the characteristics of patients with hematologic malignancies and solid ...
This study aimed to compare multiaspect characteristics in cancer and noncancer patients who receive...
Objective: There is a lack of sufficient information on the employment of home care for the treatmen...
PurposePatients with hematologic malignancies are less likely to receive specialist palliative care ...
Purpose: Patients with hematologic malignancies are less likely to receive specialist palliative car...
© 2015 Elsevier Ltd. All rights reserved. BACKGROUND: Patients with haematological malignancies are ...
Purpose: Patients with hematological malignancies (HM) have more unpredictable disease trajectories ...
We investigated the frequency and characteristics of patients with haematological malignancies (HMs)...
Background Aggressive medical management of cancer pa-tients at the end of life (EOL) is an indicato...
Objective: There is a lack of sufficient information on the employment of home care for the treatmen...
Abstract Background Haematological malignancies (leukaemias, lymphomas and myeloma) are complex canc...
BackgroundHaematological malignancies (leukaemias, lymphomas and myeloma) are complex cancers that a...
Objective: Close collaboration between the cancer care team service and the psychiatric consultation...
Background: It is important to know and decide when to end regimen for the quality of life of the pa...
Background: People with hematological malignancies can deteriorate rapidly to a terminal event and h...
This study aimed to compare the characteristics of patients with hematologic malignancies and solid ...
This study aimed to compare multiaspect characteristics in cancer and noncancer patients who receive...
Objective: There is a lack of sufficient information on the employment of home care for the treatmen...
PurposePatients with hematologic malignancies are less likely to receive specialist palliative care ...
Purpose: Patients with hematologic malignancies are less likely to receive specialist palliative car...
© 2015 Elsevier Ltd. All rights reserved. BACKGROUND: Patients with haematological malignancies are ...
Purpose: Patients with hematological malignancies (HM) have more unpredictable disease trajectories ...
We investigated the frequency and characteristics of patients with haematological malignancies (HMs)...
Background Aggressive medical management of cancer pa-tients at the end of life (EOL) is an indicato...
Objective: There is a lack of sufficient information on the employment of home care for the treatmen...
Abstract Background Haematological malignancies (leukaemias, lymphomas and myeloma) are complex canc...
BackgroundHaematological malignancies (leukaemias, lymphomas and myeloma) are complex cancers that a...
Objective: Close collaboration between the cancer care team service and the psychiatric consultation...
Background: It is important to know and decide when to end regimen for the quality of life of the pa...
Background: People with hematological malignancies can deteriorate rapidly to a terminal event and h...